Global Anti-Obesity Prescription Drugs Market Research Report 2018

Global Anti-Obesity Prescription Drugs Market Research Report 2018

1 Anti-Obesity Prescription Drugs Market Overview

1.1 Product Overview and Scope of Anti-Obesity Prescription Drugs

1.2 Anti-Obesity Prescription Drugs Segment by Type (Product Category)

1.2.1 Global Anti-Obesity Prescription Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)

1.2.2 Global Anti-Obesity Prescription Drugs Production Market Share by Type (Product Category) in 2017

1.2.3 Oral Medicine

1.2.4 Diet Patch

1.2.5 Other

1.3 Global Anti-Obesity Prescription Drugs Segment by Application

1.3.1 Anti-Obesity Prescription Drugs Consumption (Sales) Comparison by Application (2013-2025)

1.3.2 Hospitals Pharmacies

1.3.3 Retail Pharmacies

1.3.4 E-commerce

1.4 Global Anti-Obesity Prescription Drugs Market by Region (2013-2025)

1.4.1 Global Anti-Obesity Prescription Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)

1.4.2 North America Status and Prospect (2013-2025)

1.4.3 Europe Status and Prospect (2013-2025)

1.4.4 China Status and Prospect (2013-2025)

1.4.5 Japan Status and Prospect (2013-2025)

1.4.6 Southeast Asia Status and Prospect (2013-2025)

1.4.7 India Status and Prospect (2013-2025)

1.5 Global Market Size (Value) of Anti-Obesity Prescription Drugs (2013-2025)

1.5.1 Global Anti-Obesity Prescription Drugs Revenue Status and Outlook (2013-2025)

1.5.2 Global Anti-Obesity Prescription Drugs Capacity, Production Status and Outlook (2013-2025)

2 Global Anti-Obesity Prescription Drugs Market Competition by Manufacturers

2.1 Global Anti-Obesity Prescription Drugs Capacity, Production and Share by Manufacturers (2013-2018)

2.1.1 Global Anti-Obesity Prescription Drugs Capacity and Share by Manufacturers (2013-2018)

2.1.2 Global Anti-Obesity Prescription Drugs Production and Share by Manufacturers (2013-2018)

2.2 Global Anti-Obesity Prescription Drugs Revenue and Share by Manufacturers (2013-2018)

2.3 Global Anti-Obesity Prescription Drugs Average Price by Manufacturers (2013-2018)

2.4 Manufacturers Anti-Obesity Prescription Drugs Manufacturing Base Distribution, Sales Area and Product Type

2.5 Anti-Obesity Prescription Drugs Market Competitive Situation and Trends

2.5.1 Anti-Obesity Prescription Drugs Market Concentration Rate

2.5.2 Anti-Obesity Prescription Drugs Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-Obesity Prescription Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)

3.1 Global Anti-Obesity Prescription Drugs Capacity and Market Share by Region (2013-2018)

3.2 Global Anti-Obesity Prescription Drugs Production and Market Share by Region (2013-2018)

3.3 Global Anti-Obesity Prescription Drugs Revenue (Value) and Market Share by Region (2013-2018)

3.4 Global Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.5 North America Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.6 Europe Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.7 China Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.8 Japan Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.9 Southeast Asia Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.10 India Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Anti-Obesity Prescription Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)

4.1 Global Anti-Obesity Prescription Drugs Consumption by Region (2013-2018)

4.2 North America Anti-Obesity Prescription Drugs Production, Consumption, Export, Import (2013-2018)

4.3 Europe Anti-Obesity Prescription Drugs Production, Consumption, Export, Import (2013-2018)

4.4 China Anti-Obesity Prescription Drugs Production, Consumption, Export, Import (2013-2018)

4.5 Japan Anti-Obesity Prescription Drugs Production, Consumption, Export, Import (2013-2018)

4.6 Southeast Asia Anti-Obesity Prescription Drugs Production, Consumption, Export, Import (2013-2018)

4.7 India Anti-Obesity Prescription Drugs Production, Consumption, Export, Import (2013-2018)

5 Global Anti-Obesity Prescription Drugs Production, Revenue (Value), Price Trend by Type

5.1 Global Anti-Obesity Prescription Drugs Production and Market Share by Type (2013-2018)

5.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Type (2013-2018)

5.3 Global Anti-Obesity Prescription Drugs Price by Type (2013-2018)

5.4 Global Anti-Obesity Prescription Drugs Production Growth by Type (2013-2018)

6 Global Anti-Obesity Prescription Drugs Market Analysis by Application

6.1 Global Anti-Obesity Prescription Drugs Consumption and Market Share by Application (2013-2018)

6.2 Global Anti-Obesity Prescription Drugs Consumption Growth Rate by Application (2013-2018)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Anti-Obesity Prescription Drugs Manufacturers Profiles/Analysis

7.1 F Hoffmann La Roche

7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.1.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 F Hoffmann La Roche Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.1.4 Main Business/Business Overview

7.2 Arena Pharmaceuticals

7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.2.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.2.4 Main Business/Business Overview

7.3 Orexigen Therapeutics

7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.3.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.3.4 Main Business/Business Overview

7.4 Phentermine and Topiramate

7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.4.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification

7.4.2.1 Product A

7.4.2.2 Product B

7.4.3 Phentermine and Topiramate Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.4.4 Main Business/Business Overview

7.5 VIVUS, Inc

7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.5.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification

7.5.2.1 Product A

7.5.2.2 Product B

7.5.3 VIVUS, Inc Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.5.4 Main Business/Business Overview

7.6 Liraglutide

7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.6.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification

7.6.2.1 Product A

7.6.2.2 Product B

7.6.3 Liraglutide Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.6.4 Main Business/Business Overview

7.7 Bupropion and Naltrexone

7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.7.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification

7.7.2.1 Product A

7.7.2.2 Product B

7.7.3 Bupropion and Naltrexone Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.7.4 Main Business/Business Overview

7.8 Orlistat

7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.8.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification

7.8.2.1 Product A

7.8.2.2 Product B

7.8.3 Orlistat Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.8.4 Main Business/Business Overview

7.9 Bupropion and Naltrexone

7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.9.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification

7.9.2.1 Product A

7.9.2.2 Product B

7.9.3 Bupropion and Naltrexone Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.9.4 Main Business/Business Overview

7.10 Novo Nordisk

7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.10.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification

7.10.2.1 Product A

7.10.2.2 Product B

7.10.3 Novo Nordisk Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.10.4 Main Business/Business Overview

7.11 Lorcaserin

8 Anti-Obesity Prescription Drugs Manufacturing Cost Analysis

8.1 Anti-Obesity Prescription Drugs Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Anti-Obesity Prescription Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Anti-Obesity Prescription Drugs Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Anti-Obesity Prescription Drugs Major Manufacturers in 2017

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Anti-Obesity Prescription Drugs Market Forecast (2018-2025)

12.1 Global Anti-Obesity Prescription Drugs Capacity, Production, Revenue Forecast (2018-2025)

12.1.1 Global Anti-Obesity Prescription Drugs Capacity, Production and Growth Rate Forecast (2018-2025)

12.1.2 Global Anti-Obesity Prescription Drugs Revenue and Growth Rate Forecast (2018-2025)

12.1.3 Global Anti-Obesity Prescription Drugs Price and Trend Forecast (2018-2025)

12.2 Global Anti-Obesity Prescription Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)

12.2.1 North America Anti-Obesity Prescription Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.2 Europe Anti-Obesity Prescription Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.3 China Anti-Obesity Prescription Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.4 Japan Anti-Obesity Prescription Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.5 Southeast Asia Anti-Obesity Prescription Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.6 India Anti-Obesity Prescription Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.3 Global Anti-Obesity Prescription Drugs Production, Revenue and Price Forecast by Type (2018-2025)

12.4 Global Anti-Obesity Prescription Drugs Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer

Figure Picture of Anti-Obesity Prescription Drugs

Figure Global Anti-Obesity Prescription Drugs Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)

Figure Global Anti-Obesity Prescription Drugs Production Market Share by Types (Product Category) in 2017

Figure Product Picture of Oral Medicine

Table Major Manufacturers of Oral Medicine

Figure Product Picture of Diet Patch

Table Major Manufacturers of Diet Patch

Figure Product Picture of Other

Table Major Manufacturers of Other

Figure Global Anti-Obesity Prescription Drugs Consumption (K MT) by Applications (2013-2025)

Figure Global Anti-Obesity Prescription Drugs Consumption Market Share by Applications in 2017

Figure Hospitals Pharmacies Examples

Table Key Downstream Customer in Hospitals Pharmacies

Figure Retail Pharmacies Examples

Table Key Downstream Customer in Retail Pharmacies

Figure E-commerce Examples

Table Key Downstream Customer in E-commerce

Figure Global Anti-Obesity Prescription Drugs Market Size (Million USD), Comparison (K MT) and CAGR (%) by Regions (2013-2025)

Figure North America Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Europe Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure China Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Japan Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Southeast Asia Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure India Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Global Anti-Obesity Prescription Drugs Revenue (Million USD) Status and Outlook (2013-2025)

Figure Global Anti-Obesity Prescription Drugs Capacity, Production (K MT) Status and Outlook (2013-2025)

Figure Global Anti-Obesity Prescription Drugs Major Players Product Capacity (K MT) (2013-2018)

Table Global Anti-Obesity Prescription Drugs Capacity (K MT) of Key Manufacturers (2013-2018)

Table Global Anti-Obesity Prescription Drugs Capacity Market Share of Key Manufacturers (2013-2018)

Figure Global Anti-Obesity Prescription Drugs Capacity (K MT) of Key Manufacturers in 2017

Figure Global Anti-Obesity Prescription Drugs Capacity (K MT) of Key Manufacturers in 2018

Figure Global Anti-Obesity Prescription Drugs Major Players Product Production (K MT) (2013-2018)

Table Global Anti-Obesity Prescription Drugs Production (K MT) of Key Manufacturers (2013-2018)

Table Global Anti-Obesity Prescription Drugs Production Share by Manufacturers (2013-2018)

Figure 2017 Anti-Obesity Prescription Drugs Production Share by Manufacturers

Figure 2017 Anti-Obesity Prescription Drugs Production Share by Manufacturers

Figure Global Anti-Obesity Prescription Drugs Major Players Product Revenue (Million USD) (2013-2018)

Table Global Anti-Obesity Prescription Drugs Revenue (Million USD) by Manufacturers (2013-2018)

Table Global Anti-Obesity Prescription Drugs Revenue Share by Manufacturers (2013-2018)

Table 2017 Global Anti-Obesity Prescription Drugs Revenue Share by Manufacturers

Table 2018 Global Anti-Obesity Prescription Drugs Revenue Share by Manufacturers

Table Global Market Anti-Obesity Prescription Drugs Average Price (USD/MT) of Key Manufacturers (2013-2018)

Figure Global Market Anti-Obesity Prescription Drugs Average Price (USD/MT) of Key Manufacturers in 2017

Table Manufacturers Anti-Obesity Prescription Drugs Manufacturing Base Distribution and Sales Area

Table Manufacturers Anti-Obesity Prescription Drugs Product Category

Figure Anti-Obesity Prescription Drugs Market Share of Top 3 Manufacturers

Figure Anti-Obesity Prescription Drugs Market Share of Top 5 Manufacturers

Table Global Anti-Obesity Prescription Drugs Capacity (K MT) by Region (2013-2018)

Figure Global Anti-Obesity Prescription Drugs Capacity Market Share by Region (2013-2018)

Figure Global Anti-Obesity Prescription Drugs Capacity Market Share by Region (2013-2018)

Figure 2017 Global Anti-Obesity Prescription Drugs Capacity Market Share by Region

Table Global Anti-Obesity Prescription Drugs Production by Region (2013-2018)

Figure Global Anti-Obesity Prescription Drugs Production (K MT) by Region (2013-2018)

Figure Global Anti-Obesity Prescription Drugs Production Market Share by Region (2013-2018)

Figure 2017 Global Anti-Obesity Prescription Drugs Production Market Share by Region

Table Global Anti-Obesity Prescription Drugs Revenue (Million USD) by Region (2013-2018)

Table Global Anti-Obesity Prescription Drugs Revenue Market Share by Region (2013-2018)

Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Region (2013-2018)

Table 2017 Global Anti-Obesity Prescription Drugs Revenue Market Share by Region

Figure Global Anti-Obesity Prescription Drugs Capacity, Production (K MT) and Growth Rate (2013-2018)

Table Global Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Table North America Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Table Europe Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Table China Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Table Japan Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Table Southeast Asia Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Table India Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Table Global Anti-Obesity Prescription Drugs Consumption (K MT) Market by Region (2013-2018)

Table Global Anti-Obesity Prescription Drugs Consumption Market Share by Region (2013-2018)

Figure Global Anti-Obesity Prescription Drugs Consumption Market Share by Region (2013-2018)

Figure 2017 Global Anti-Obesity Prescription Drugs Consumption (K MT) Market Share by Region

Table North America Anti-Obesity Prescription Drugs Production, Consumption, Import & Export (K MT) (2013-2018)

Table Europe Anti-Obesity Prescription Drugs Production, Consumption, Import & Export (K MT) (2013-2018)

Table China Anti-Obesity Prescription Drugs Production, Consumption, Import & Export (K MT) (2013-2018)

Table Japan Anti-Obesity Prescription Drugs Production, Consumption, Import & Export (K MT) (2013-2018)

Table Southeast Asia Anti-Obesity Prescription Drugs Production, Consumption, Import & Export (K MT) (2013-2018)

Table India Anti-Obesity Prescription Drugs Production, Consumption, Import & Export (K MT) (2013-2018)

Table Global Anti-Obesity Prescription Drugs Production (K MT) by Type (2013-2018)

Table Global Anti-Obesity Prescription Drugs Production Share by Type (2013-2018)

Figure Production Market Share of Anti-Obesity Prescription Drugs by Type (2013-2018)

Figure 2017 Production Market Share of Anti-Obesity Prescription Drugs by Type

Table Global Anti-Obesity Prescription Drugs Revenue (Million USD) by Type (2013-2018)

Table Global Anti-Obesity Prescription Drugs Revenue Share by Type (2013-2018)

Figure Production Revenue Share of Anti-Obesity Prescription Drugs by Type (2013-2018)

Figure 2017 Revenue Market Share of Anti-Obesity Prescription Drugs by Type

Table Global Anti-Obesity Prescription Drugs Price (USD/MT) by Type (2013-2018)

Figure Global Anti-Obesity Prescription Drugs Production Growth by Type (2013-2018)

Table Global Anti-Obesity Prescription Drugs Consumption (K MT) by Application (2013-2018)

Table Global Anti-Obesity Prescription Drugs Consumption Market Share by Application (2013-2018)

Figure Global Anti-Obesity Prescription Drugs Consumption Market Share by Applications (2013-2018)

Figure Global Anti-Obesity Prescription Drugs Consumption Market Share by Application in 2017

Table Global Anti-Obesity Prescription Drugs Consumption Growth Rate by Application (2013-2018)

Figure Global Anti-Obesity Prescription Drugs Consumption Growth Rate by Application (2013-2018)

Table F Hoffmann La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table F Hoffmann La Roche Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Figure F Hoffmann La Roche Anti-Obesity Prescription Drugs Production Growth Rate (2013-2018)

Figure F Hoffmann La Roche Anti-Obesity Prescription Drugs Production Market Share (2013-2018)

Figure F Hoffmann La Roche Anti-Obesity Prescription Drugs Revenue Market Share (2013-2018)

Table Arena Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Arena Pharmaceuticals Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Figure Arena Pharmaceuticals Anti-Obesity Prescription Drugs Production Growth Rate (2013-2018)

Figure Arena Pharmaceuticals Anti-Obesity Prescription Drugs Production Market Share (2013-2018)

Figure Arena Pharmaceuticals Anti-Obesity Prescription Drugs Revenue Market Share (2013-2018)

Table Orexigen Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Orexigen Therapeutics Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Figure Orexigen Therapeutics Anti-Obesity Prescription Drugs Production Growth Rate (2013-2018)

Figure Orexigen Therapeutics Anti-Obesity Prescription Drugs Production Market Share (2013-2018)

Figure Orexigen Therapeutics Anti-Obesity Prescription Drugs Revenue Market Share (2013-2018)

Table Phentermine and Topiramate Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Phentermine and Topiramate Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Figure Phentermine and Topiramate Anti-Obesity Prescription Drugs Production Growth Rate (2013-2018)

Figure Phentermine and Topiramate Anti-Obesity Prescription Drugs Production Market Share (2013-2018)

Figure Phentermine and Topiramate Anti-Obesity Prescription Drugs Revenue Market Share (2013-2018)

Table VIVUS, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table VIVUS, Inc Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Figure VIVUS, Inc Anti-Obesity Prescription Drugs Production Growth Rate (2013-2018)

Figure VIVUS, Inc Anti-Obesity Prescription Drugs Production Market Share (2013-2018)

Figure VIVUS, Inc Anti-Obesity Prescription Drugs Revenue Market Share (2013-2018)

Table Liraglutide Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Liraglutide Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Figure Liraglutide Anti-Obesity Prescription Drugs Production Growth Rate (2013-2018)

Figure Liraglutide Anti-Obesity Prescription Drugs Production Market Share (2013-2018)

Figure Liraglutide Anti-Obesity Prescription Drugs Revenue Market Share (2013-2018)

Table Bupropion and Naltrexone Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bupropion and Naltrexone Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Figure Bupropion and Naltrexone Anti-Obesity Prescription Drugs Production Growth Rate (2013-2018)

Figure Bupropion and Naltrexone Anti-Obesity Prescription Drugs Production Market Share (2013-2018)

Figure Bupropion and Naltrexone Anti-Obesity Prescription Drugs Revenue Market Share (2013-2018)

Table Orlistat Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Orlistat Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Figure Orlistat Anti-Obesity Prescription Drugs Production Growth Rate (2013-2018)

Figure Orlistat Anti-Obesity Prescription Drugs Production Market Share (2013-2018)

Figure Orlistat Anti-Obesity Prescription Drugs Revenue Market Share (2013-2018)

Table Bupropion and Naltrexone Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bupropion and Naltrexone Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Figure Bupropion and Naltrexone Anti-Obesity Prescription Drugs Production Growth Rate (2013-2018)

Figure Bupropion and Naltrexone Anti-Obesity Prescription Drugs Production Market Share (2013-2018)

Figure Bupropion and Naltrexone Anti-Obesity Prescription Drugs Revenue Market Share (2013-2018)

Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novo Nordisk Anti-Obesity Prescription Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)

Figure Novo Nordisk Anti-Obesity Prescription Drugs Production Growth Rate (2013-2018)

Figure Novo Nordisk Anti-Obesity Prescription Drugs Production Market Share (2013-2018)

Figure Novo Nordisk Anti-Obesity Prescription Drugs Revenue Market Share (2013-2018)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Anti-Obesity Prescription Drugs

Figure Manufacturing Process Analysis of Anti-Obesity Prescription Drugs

Figure Anti-Obesity Prescription Drugs Industrial Chain Analysis

Table Raw Materials Sources of Anti-Obesity Prescription Drugs Major Manufacturers in 2017

Table Major Buyers of Anti-Obesity Prescription Drugs

Table Distributors/Traders List

Figure Global Anti-Obesity Prescription Drugs Capacity, Production (K MT) and Growth Rate Forecast (2018-2025)

Figure Global Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Global Anti-Obesity Prescription Drugs Price (Million USD) and Trend Forecast (2018-2025)

Table Global Anti-Obesity Prescription Drugs Production (K MT) Forecast by Region (2018-2025)

Figure Global Anti-Obesity Prescription Drugs Production Market Share Forecast by Region (2018-2025)

Table Global Anti-Obesity Prescription Drugs Consumption (K MT) Forecast by Region (2018-2025)

Figure Global Anti-Obesity Prescription Drugs Consumption Market Share Forecast by Region (2018-2025)

Figure North America Anti-Obesity Prescription Drugs Production (K MT) and Growth Rate Forecast (2018-2025)

Figure North America Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table North America Anti-Obesity Prescription Drugs Production, Consumption, Export and Import (K MT) Forecast (2018-2025)

Figure Europe Anti-Obesity Prescription Drugs Production (K MT) and Growth Rate Forecast (2018-2025)

Figure Europe Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Europe Anti-Obesity Prescription Drugs Production, Consumption, Export and Import (K MT) Forecast (2018-2025)

Figure China Anti-Obesity Prescription Drugs Production (K MT) and Growth Rate Forecast (2018-2025)

Figure China Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table China Anti-Obesity Prescription Drugs Production, Consumption, Export and Import (K MT) Forecast (2018-2025)

Figure Japan Anti-Obesity Prescription Drugs Production (K MT) and Growth Rate Forecast (2018-2025)

Figure Japan Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Japan Anti-Obesity Prescription Drugs Production, Consumption, Export and Import (K MT) Forecast (2018-2025)

Figure Southeast Asia Anti-Obesity Prescription Drugs Production (K MT) and Growth Rate Forecast (2018-2025)

Figure Southeast Asia Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Southeast Asia Anti-Obesity Prescription Drugs Production, Consumption, Export and Import (K MT) Forecast (2018-2025)

Figure India Anti-Obesity Prescription Drugs Production (K MT) and Growth Rate Forecast (2018-2025)

Figure India Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table India Anti-Obesity Prescription Drugs Production, Consumption, Export and Import (K MT) Forecast (2018-2025)

Table Global Anti-Obesity Prescription Drugs Production (K MT) Forecast by Type (2018-2025)

Figure Global Anti-Obesity Prescription Drugs Production (K MT) Forecast by Type (2018-2025)

Table Global Anti-Obesity Prescription Drugs Revenue (Million USD) Forecast by Type (2018-2025)

Figure Global Anti-Obesity Prescription Drugs Revenue Market Share Forecast by Type (2018-2025)

Table Global Anti-Obesity Prescription Drugs Price Forecast by Type (2018-2025)

Table Global Anti-Obesity Prescription Drugs Consumption (K MT) Forecast by Application (2018-2025)

Figure Global Anti-Obesity Prescription Drugs Consumption (K MT) Forecast by Application (2018-2025)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Source